XML 22 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities    
Net loss $ (22,516,889) $ (5,871,642)
Adjustments to reconcile net loss to cash used in operating activities, net of acquisitions:    
Stock-based compensation expense 423,911 332,266
Depreciation and amortization 6,636,593 4,277,843
Bad debt expense 654,820 2,013,167
Gain on acquisition 0 (6,948,686)
Deferred federal income tax 5,306,000 0
Inventory impairment charge 0 467,911
Net decrease in fair value of derivative liability (5,479,463) 0
Reduction in contingent consideration (6,069,000) (5,248,588)
Impairment of goodwill 4,922,353 0
Changes in operating assets and liabilities:    
Accounts receivable 1,929,871 714,698
Inventory 9,072,305 1,891,932
Prepaid expenses 48,438 (12,586)
Costs in excess of billings 779,285 (779,285)
Accounts payable and accrued expenses (8,539,803) 7,255,722
Deferred revenue (139,319) 463,210
Other 0 (81,450)
Net cash used in operating activities (12,970,898) (1,525,488)
Cash flows from investing activities    
Note receivable 2,495,180 (3,150,000)
Payments on capital leases (172,654) 0
Net proceeds from the sale of assets 92,271 0
Acquisition, net (1,082,649) (31,114,140)
Purchase of fixed assets (1,811,653) (5,940,890)
Net cash used in investing activities (479,505) (40,205,030)
Cash flows from financing activities    
Proceeds from revolving note 94,271,900 0
Payments on revolving note (92,527,778) 0
Proceeds from exercise of common stock options and warrants 11,306 370,337
Proceeds from Preferred A stock to common stock conversion 0 0
Proceeds from sale of stock 0 17,315,143
Proceeds from preferred Series B stock/share offering 23,557,553 0
Payments on contingent consideration 0 (136,662)
Proceeds from notes payable 2,305,277 41,309,433
Payments made on notes payable (19,419,567) (11,337,128)
Debt issuance cost 0 (2,452,157)
Net cash provided by financing activities 8,198,691 45,068,966
Net change in cash and cash equivalents (5,251,712) 3,338,448
Cash and cash equivalents at beginning of the period 6,017,076 2,678,628
Cash and cash equivalents at end of period 765,364 6,017,076
SUPPLEMENTAL INFORMATION    
Cash paid for interest during the year 3,563,145 2,636,690
Cash paid for income taxes during the year 0 122,763
NON-CASH INVESTING AND FINANCING TRANSACTIONS    
Dividends accrued for payment in 2016 376,571 0
Stock issued 200,000 0
Heartland Group Holdings, LLC and Omega Refining    
NON-CASH INVESTING AND FINANCING TRANSACTIONS    
Stock issued 0 9,004,000
Series A Preferred Stock    
NON-CASH INVESTING AND FINANCING TRANSACTIONS    
Conversion of Preferred Stock into common stock 17 689
Series B Preferred Stock    
NON-CASH INVESTING AND FINANCING TRANSACTIONS    
Conversion of Preferred Stock into common stock 100,795 0
Dividends accrued for payment in 2016 376,570 0
Dividends paid by stock in kind 402,740 0
Beneficial conversion feature 5,682,741 0
Accretion of discount on Series B Preferred Stock $ 1,585,843 $ 0